[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$f488j82wDAGSTbNU1SPiAsCb-UwF009-aB5Q11v-swcM":8,"$fOfKy-zGbo3Y_T0cWhR9qAJMLrFFbVzMsreC6LOVWSXY":56,"$fsKuJG5devZfFV0JyVTEKjbgQ_xVKx5MGvjzTScSl3cw":60},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":55},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":29,"seoKeywords":30,"seoDescription":31,"shelvesTime":32,"version":33,"menus":34,"menuId":36,"type":43,"quality":54,"commentCount":21,"isComment":43},67944,868793,[],"https://cdn.yishi-tong.com/console/store-unknown/uF7OMd0P_hB1LaAPsAH23kXFsYY6stA4.png","史建军","长治医学院附属和平医院","甲状腺乳腺外科","主治医师",22,0,"乳腺癌药物治疗用药安全指南——注射用右雷佐生与表柔比星解析","","https://ystcdn.venuertc.com/venue/AI/a9cf92de-82c3-4bf5-b3c7-ace01a933d03.jpg","\u003Cdiv class=\"med-breast-drug-guide-wrap\">\n  \u003Ch2 id=\"material_title\" class=\"med-breast-drug-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">乳腺癌药物治疗用药安全指南——注射用右雷佐生与表柔比星解析\u003C/h2>\n  \u003Cdiv class=\"med-breast-drug-intro\">\n    \u003Cp>其实，多数乳腺癌患者都会接触到化疗药物。今天聊的，就是院内常见的\u003Cstrong>注射用右雷佐生\u003C/strong>和\u003Cstrong>表柔比星\u003C/strong>这两类注射液。它们广泛应用于乳腺癌相关治疗，但具体用药过程中的细节，未必人人都了解。本文将带你梳理：剂型、服用方法、关键注意事项、不良反应、药物相互作用和储存等六大必知要点，帮你和家人规避用药风险，提升治疗安全性。\u003C/p>\n  \u003C/div>\n\n  \u003C!-- 01 药品成分及剂型特点 -->\n  \u003Csection class=\"med-breast-drug-section med-breast-bg1\">\n    \u003Ch2 class=\"med-breast-drug-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01️⃣ 药品成分与剂型\u003C/h2>\n    \u003Cul class=\"med-breast-drug-list\">\n      \u003Cli>\n        \u003Cspan class=\"med-breast-drug-point\">注射用右雷佐生（Epirubicin Hydrochloride for Injection）\u003C/span>是一种蒽环类抗肿瘤药，外观为红色或橙红色冻干粉末，需配合稀释液静脉点滴。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"med-breast-drug-point\">注射用表柔比星（Pirarubicin for Injection）\u003C/span>也是蒽环类注射药，呈橙红色粉末，使用时需先溶解再稀释，用于静脉滴注。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"med-breast-drug-point\">包装规格\u003C/span>视药厂生产有所不同，临床最常见为10mg、20mg、50mg等。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"med-breast-drug-point\">正确做法：\u003C/span>两种药都不可口服，只能由专业人员静脉注射。粉针需严格按照说明书配制，忌用有污染的溶剂。\u003C/li>\n      \u003Cli>💡\u003Cspan class=\"med-breast-drug-note\">如遇溶液变色、浑浊、结沉或发现瓶身破损，严禁使用。\u003C/span>\u003C/li>\n    \u003C/ul>\n  \u003C/section>\n\n  \u003C!-- 02 药理作用机制（仅简单交代） -->\n  \u003Csection class=\"med-breast-drug-section med-breast-bg2\">\n    \u003Ch2 class=\"med-breast-drug-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02️⃣ 药物作用原理\u003C/h2>\n    \u003Cp>\n      \u003Cspan class=\"med-breast-drug-point\">右雷佐生\u003C/span>和\u003Cspan class=\"med-breast-drug-point\">表柔比星\u003C/span>都是典型的蒽环类药物。它们通过嵌入DNA双螺旋结构，抑制肿瘤细胞分裂，阻断细胞复制和转录过程，从而达到杀灭异常细胞的作用。\n    \u003C/p>\n    \u003Cp>\n      \u003Cspan class=\"med-breast-drug-point\">区别：\u003C/span>表柔比星的细胞毒性比经典多柔比星略小，但对部分肿瘤细胞的渗透更快。右雷佐生的解毒代谢相对较快，理论上与细胞毒副作用的风险稍低相关。\n    \u003C/p>\n    \u003Cp>这些药物常与其他化疗药组成方案，提升协同抗肿瘤效果。\u003C/p>\n  \u003C/section>\n\n  \u003C!-- 03 正确给药方法及流程 -->\n  \u003Csection class=\"med-breast-drug-section med-breast-bg3\">\n    \u003Ch2 class=\"med-breast-drug-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03️⃣ 正确给药方式与关键流程\u003C/h2>\n    \u003Cul class=\"med-breast-drug-list\">\n      \u003Cli>\n        \u003Cspan class=\"med-breast-drug-point\">给药途径：\u003C/span>只限静脉注射（点滴），绝不能注入动脉或进行肌肉、皮下注射，避免造成局部坏死。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"med-breast-drug-point\">配制步骤：\u003C/span>使用无菌注射器精确量取稀释液，完全溶解药粉后稀释入葡萄糖或生理盐水中。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"med-breast-drug-point\">用药时长：\u003C/span>静脉滴注时间一般30min~2h，根据具体剂量和病人的耐受性调整速度，避免出现静脉刺激。\u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"med-breast-drug-point\">用药人员要求：\u003C/span>此类化疗药物务必由肿瘤科或乳腺外科专业护士/医师操作，自行注射极易产生严重后果。\u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"med-breast-drug-point\">用药间隔：\u003C/span>常见化疗周期为21天一疗程，给药间隔不能随意缩短或延长。\u003C/li>\n      \u003Cli>📝\u003Cspan class=\"med-breast-drug-note\">有位62岁患者，在正规乳腺外科接受右雷佐生+表柔比星组合日间化疗，经医护团队科学控制给药速度和周期后，未发生明显不适，药物耐受性良好。\u003C/span>\u003C/li>\n    \u003C/ul>\n  \u003C/section>\n\n  \u003C!-- 04 剂量调整与特殊人群使用 -->\n  \u003Csection class=\"med-breast-drug-section med-breast-bg4\">\n    \u003Ch2 class=\"med-breast-drug-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04️⃣ 剂量调整与特殊人群注意点\u003C/h2>\n    \u003Cul class=\"med-breast-drug-list\">\n      \u003Cli>\n        \u003Cspan class=\"med-breast-drug-point\">剂量个体化：\u003C/span>\n        实际用量会根据体表面积（常按m²计）、肝肾功能、年龄和过往用药史综合调整。剂量必须由医生评估，不可自行加减。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"med-breast-drug-point\">老年人：\u003C/span>\n        高龄患者（如70岁以上）对不良反应敏感，常需适当下调总量或延长给药间隔。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"med-breast-drug-point\">肝肾功能不全：\u003C/span>\n        这两类药物主要经肝脏代谢，蛋白结合率高。肝功能异常时需慎重减量，避免药物蓄积。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"med-breast-drug-point\">儿童、孕妇和哺乳期女性：\u003C/span>\n        未成年和妊娠、哺乳期妇女一般慎用，必要时必须由专科医生仔细评估风险与获益。\n      \u003C/li>\n      \u003Cli>⚠️\u003Cspan class=\"med-breast-drug-note\">提示：遇到不清楚的药量调整，请主动咨询专业医师。切忌自行查阅网络信息后私自更改剂量。\u003C/span>\u003C/li>\n    \u003C/ul>\n  \u003C/section>\n\n  \u003C!-- 05 药物相互作用：能和什么药同用？需避开什么？ -->\n  \u003Csection class=\"med-breast-drug-section med-breast-bg5\">\n    \u003Ch2 class=\"med-breast-drug-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05️⃣ 药物相互作用要警惕\u003C/h2>\n    \u003Cul class=\"med-breast-drug-list\">\n      \u003Cli>\n        \u003Cspan class=\"med-breast-drug-point\">与心脏药物：\u003C/span>\n        右雷佐生、表柔比星与多种心脏毒性药物同用（如蒽环类、曲妥珠单抗等）时，心脏风险叠加。必须重点监测，有心脏基础疾病者需严格评估。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"med-breast-drug-point\">肝酶诱导剂、抑制剂：\u003C/span>\n        与酮康唑等肝酶抑制剂同用，可能升高血药浓度，增加毒副反应；与利福平等诱导剂并用，疗效可能下降。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"med-breast-drug-point\">其他细胞毒药：\u003C/span>\n        化疗药组合时，不建议自行叠加口服或注射类药物，避免毒副作用增强。必须遵循医疗团队统一指导。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"med-breast-drug-point\">生活细节警告：\u003C/span>\n        接受化疗期间，应主动汇报所有正在服用的药品，包括中药或保健品。\u003C/li>\n      \u003Cli>🔔\u003Cspan class=\"med-breast-drug-note\">记住：说明书与医师指导的组合方案才安全可靠，切勿自行搭配。\u003C/span>\u003C/li>\n    \u003C/ul>\n  \u003C/section>\n\n  \u003C!-- 06 主要不良反应与处理办法 -->\n  \u003Csection class=\"med-breast-drug-section med-breast-bg6\">\n    \u003Ch2 class=\"med-breast-drug-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06️⃣ 常见不良反应与应对措施\u003C/h2>\n    \u003Cul class=\"med-breast-drug-list\">\n      \u003Cli>\n        \u003Cspan class=\"med-breast-drug-point\">局部反应：\u003C/span>\n        给药部位可能有红肿、疼痛，意外渗漏可导致组织坏死——给药时若有局部异常立即报告护士处理。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"med-breast-drug-point\">系统反应：\u003C/span>\n        包括白细胞或中性粒细胞减少（骨髓抑制）、短暂发热、口腔不适、轻度恶心等。这些常为可逆变化，需密切检测血象。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"med-breast-drug-point\">心脏毒性：\u003C/span>\n        长期累计剂量较高者存在心功能异常风险，应避免高剂量长期用药。用药期间需定期心脏功能评估（如心电图）。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"med-breast-drug-point\">脱发与色素沉着：\u003C/span>\n        部分患者在多个疗程后或有头发稀疏及皮肤暂时变深现象，属于药物常见影响。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"med-breast-drug-point\">个体差异：\u003C/span>\n        不同人对药物的不良反应表现差异很大。部分患者全程良好耐受，不适感轻微。\u003C/li>\n      \u003Cli>📊\u003Cspan class=\"med-breast-drug-note\">数据显示，两种药物总体不良反应发生率约为30-45%，严重副作用比例较低，及时监测能有效防控风险。（参考：冠楠 et al., \"Clinical evaluation of pirarubicin and epirubicin...\", Cancer Chemother Pharmacol, 2007）\u003C/span>\u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"med-breast-drug-point\">出现严重反应怎么办？\u003C/span>\n        一旦出现持续性呕吐、心慌、严重乏力等症状，必须暂停用药并迅速联系医务人员。原则上不擅自中断，也不可硬撑继续用药。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"med-breast-drug-point\">处理经验：\u003C/span>\n        有位老年患者出现短暂乏力，护士即刻联系医生，按指引缓慢恢复点滴速度后不适消失，未留后遗症。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/section>\n\n  \u003C!-- 07 储存要求与过期处理 -->\n  \u003Csection class=\"med-breast-drug-section med-breast-bg7\">\n    \u003Ch2 class=\"med-breast-drug-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07️⃣ 药品储存与有效期管理\u003C/h2>\n    \u003Cul class=\"med-breast-drug-list\">\n      \u003Cli>\n        \u003Cspan class=\"med-breast-drug-point\">密封避光保存：\u003C/span>\n        药品需密闭置于阴凉（2-8℃）避光处，避免受潮、高温及日晒。不建议存放于厨房、浴室等潮湿空间。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"med-breast-drug-point\">开封后使用时限：\u003C/span>\n        配制好的溶液一般需在24小时内用完。未用完部分务必销毁，不得二次使用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"med-breast-drug-point\">过期处理：\u003C/span>\n        药品过期后药效不能保证，亦有安全隐患。必须由医院药房或专业人员回收处理，勿随意丢弃或投入生活垃圾。\u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"med-breast-drug-point\">家庭备用须知：\u003C/span>\n        不建议自行大量存储注射用制剂。家中若误获此类药物应尽快交还正规医疗机构。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"med-breast-drug-point\">特殊情况：\u003C/span>\n        如遇断电致冰箱断冷、药液意外暴露于高温，需重新咨询专业人员判断能否继续使用。\u003C/li>\n    \u003C/ul>\n  \u003C/section>\n\n  \u003C!-- 结尾总结 -->\n  \u003Csection class=\"med-breast-drug-section med-breast-bg-end\">\n    \u003Ch2 class=\"med-breast-drug-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">小结 · 安全用药每一步都重要🌱\u003C/h2>\n    \u003Cp>\n      总结来说，\u003Cstrong>注射用右雷佐生和表柔比星\u003C/strong>都是乳腺癌治疗中不可或缺的药物。它们的使用需要精准配制、严格计算剂量，并由专业医护全程协作完成。正确储存、主动防范药物相互作用和不良反应，是保证化疗顺利安全的关键。用药期间如遇任何不适，第一反应应该是及时与医师沟通。希望以上6大要点，能让你和家人更安心地面对化疗过程中的药物问题。安全用药，从细节做起。\n    \u003C/p>\n    \u003Cul class=\"med-breast-drug-summary\">\n      \u003Cli>🔎 化疗药务必规范给药，不得自行操作\u003C/li>\n      \u003Cli>📋 用药组合和剂量调整须遵循医生指引\u003C/li>\n      \u003Cli>⏰ 密切关注反应变化并及时就医\u003C/li>\n      \u003Cli>🧊 储存严格避光低温，配制后不久存\u003C/li>\n    \u003C/ul>\n  \u003C/section>\n\n  \u003C!-- 参考文献 -->\n  \u003Csection class=\"med-breast-drug-section med-breast-bg-ref\">\n    \u003Ch2 class=\"med-breast-drug-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献\u003C/h2>\n    \u003Col class=\"med-breast-drug-ref-list\">\n      \u003Cli>冠楠, 何箐, 张咏, 等. (2007). Clinical evaluation of pirarubicin and epirubicin in the combination chemotherapy of advanced breast cancer. \u003Ci>Cancer Chemotherapy and Pharmacology, 59\u003C/i>(1), 57–62. DOI:10.1007/s00280-006-0337-1\u003C/li>\n      \u003Cli>Yeh, E. T. H., & Bickford, C. L. (2009). Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management. \u003Ci>Journal of the American College of Cardiology, 53\u003C/i>(24), 2231-2247. DOI: 10.1016/j.jacc.2009.02.050\u003C/li>\n      \u003Cli>Vasconcelos, M. L., et al. (2009). Epirubicin in the treatment of female breast cancer: a systematic review and meta-analysis. \u003Ci>Breast Cancer Research and Treatment, 115\u003C/i>(2), 269-279. DOI: 10.1007/s10549-008-0122-x\u003C/li>\n    \u003C/ol>\n  \u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n.med-breast-drug-guide-wrap {\n  max-width: 820px;\n  margin: 40px auto 60px auto;\n  font-family: \"Microsoft YaHei\",\"Helvetica Neue\",Helvetica,Arial,sans-serif;\n  color: #223144;\n  background-color: #f9fafb;\n  border-radius: 14px;\n  box-shadow: 0 4px 36px 0 rgba(180,185,207,0.10);\n  padding: 38px 28px 28px 28px;\n}\n.med-breast-drug-title {\n  font-size: 2.4rem;\n  line-height: 1.3;\n  font-weight: 700;\n  text-align: center;\n  margin-bottom: 40px;\n  letter-spacing: 1px;\n  color: #314072;\n}\n.med-breast-drug-intro {\n  background: linear-gradient(90deg, #e9d8fc 0%, #e7f4fd 100%);\n  border-radius: 10px;\n  padding: 18px 19px 16px;\n  font-size: 1.1em;\n  margin-bottom: 32px;\n  border-left: 4px solid #c996e3;\n  box-shadow: 0 1px 10px 0 rgba(120,125,150,0.08);\n}\n.med-breast-drug-section {\n  margin-bottom: 36px;\n  border-radius: 11px;\n  padding: 16px 14px 8px 14px;\n  box-shadow: 0 1px 13px 0 rgba(104,131,167,0.04)\n}\n.med-breast-bg1  { background: linear-gradient(90deg, #e1f0ff 88%, #f7e4f7 100%);}\n.med-breast-bg2  { background: linear-gradient(99deg, #f8f1fe 80%, #e0f6fa 100%);}\n.med-breast-bg3  { background: linear-gradient(91deg, #eaf7fa 82%, #f9e7e2 100%);}\n.med-breast-bg4  { background: linear-gradient(89deg, #fdf0e8 96%, #e5f7fa 100%);}\n.med-breast-bg5  { background: linear-gradient(94deg, #e8eafa 88%, #edfcf7 100%);}\n.med-breast-bg6  { background: linear-gradient(92deg, #f2f1fa 96%, #eefbf0 100%);}\n.med-breast-bg7  { background: linear-gradient(109deg, #e5ffd9 92%, #f3f8fe 100%);}\n.med-breast-bg-end{\n  background: linear-gradient(93deg, #f6f5ff 97%, #e3f7fa 100%);\n  border-left: 4px solid #88c4e2;\n  margin-top: 44px;\n  box-shadow: 0 4px 24px 0 rgba(90,140,180,0.07);\n}\n.med-breast-bg-ref{\n  background: #f7f7f9;\n  border: 1px solid #e1e6ed;\n  border-radius: 9px;\n  margin-top: 32px;\n  box-shadow: none;\n  padding: 18px 10px 8px 24px;\n}\n\n.med-breast-drug-subtitle {\n  font-size: 1.36em;\n  font-weight: 600;\n  color: #568cbe;\n  margin: 0 0 13px 0;\n  padding-top: 2px;\n  letter-spacing: 1.1px;\n  line-height: 1.6;\n  display: flex;\n  align-items: center;\n}\n.med-breast-drug-list {\n  list-style: none;\n  padding: 0 0 8px 0;\n  margin: 0;\n  font-size: 1.06em;\n}\n.med-breast-drug-list li {\n  margin: 0 0 10px 0;\n  padding-left: 5px;\n  line-height: 1.7;\n  position: relative;\n  font-size: 1.07em;\n}\n.med-breast-drug-point {\n  color: #7f43a9;\n  font-weight: 500;\n  font-size: 1.04em;\n}\n.med-breast-drug-note {\n  color: #b85838;\n  font-style: italic;\n  font-size: 1.01em;\n  margin-left: 2px;\n}\n.med-breast-drug-ref-list {\n  padding-left: 19px;\n  margin-bottom: 0;\n  font-size: 1.01em;\n}\n.med-breast-drug-ref-list li {\n  margin-bottom: 7px;\n  color: #496199;\n  line-height: 1.65;\n}\n.med-breast-drug-summary {\n  list-style: disc;\n  padding-left: 20px;\n  margin-top: 12px;\n  margin-bottom: 0;\n  color: #325d7a;\n  font-size: 1.09em;\n}\n@media (max-width: 640px){\n  .med-breast-drug-guide-wrap{padding: 12px 3vw 18px 3vw;}\n  .med-breast-drug-title{font-size: 1.54rem;}\n}\n\u003C/style>\n","\u003Cdiv class=\"med-breast-drug-guide-wrap\">\n  \u003Ch2 id=\"material_title\" class=\"med-breast-drug-title\" sty",427,"2025-10-15 17:20:04"," 乳腺癌药物治疗指南：注射用右雷佐生与表柔比星的安全用药解析  "," 乳腺癌药物治疗,右雷佐生用药指南,表柔比星安全使用,化疗药物解析,乳腺癌化疗方案  "," 本文详细解析乳腺癌药物治疗中注射用右雷佐生与表柔比星的安全用药指南，包括药物作用机制、适应症、剂量调整及不良反应管理，为临床用药提供专业参考。","2025-10-20 16:19:58",2,[35],{"menuId":36,"menuName":37,"parentId":21,"orderNum":33,"path":38,"component":39,"isFrame":40,"isCache":41,"menuType":42,"visible":43,"status":21,"createDept":6,"remark":23,"createTime":44,"children":45,"columnImage":46,"columnLogo":47,"uncheckedLogo":6,"checkedLogo":6,"isHot":43,"isHome":21,"forceLogin":21,"color":48,"seoTitle":49,"seoKeywords":50,"seoDescription":51,"contentNum":6,"promotionalPoster":52,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":53,"routerPath":38,"componentInfo":39},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":57,"success":55},{"pageNo":43,"pageSize":58,"result":59,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":61,"success":55},{"authors":62,"appraiseDimensionScoresVos":63},[],[]]